According to Bloomberg, recent years have seen the strong performance of biopharmaceutical enterprises in Hong Kong stock market. Bonnie Chan,…
Search Results: Tot Biopharm (105)
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group”or the “Company”), a biopharmaceutical company focuses on the development of…
— Supplemental NDAs for Toripalimab filed — Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing…
Profit Attributable to the Owners of the Company Increased by 153.3% Actively Develop New Products Reform and Replenish the Sales…
Revenue and Profit Attributable to Owners of the Company from Continuing Operations are RMB1,054.5 million and RMB170.5 million, respectively; Multiple…
SinoMab BioScience Limited (“SinoMab” of the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development,…
Prominent Advantages of Core Products Though the COVID-19 pandemic has blanketed the capital market in 2020, biotech stocks have stood…
Net Profit Surged by 193.5% YOY to approx. RMB265.9 million; Accelerating the Integration of Innovative Drugs Industrial Chain Viva Biotech…
Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary…
CStone Pharmaceuticals (“CStone”; Stock Code: 2616.HK), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and…
After the market closed on 21 February 2020, Hang Seng Indexes Company Limited announced the results of its review of…
Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global…
SinoMab BioScience Limited (“SinoMab BioScience” or the “Company”, together with its subsidiaries, the “Group”; stock code: 3681.HK), a Hong Kong-based…
SinoMab BioScience Limited (“SinoMab BioScience” or the “Company”, together with its subsidiaries, the “Group”; stock code: 3681.HK), a Hong Kong-based…
MIT’s Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of…
If there is an indicator to measure whether the company is good or not from Buffett’s perspective, it’s believed that…
From the Internet era to the artificial intelligent era, technological innovations have subverted the changes in the industry. In the…
HONG KONG – (ACN Newswire) – Innovent Biologics [Innovent; HKG:1801], a China Suzhou-based biopharmaceutical company, completes its initial public offering in…
HONG KONG – (ACN Newswire) – Innovent Biologics [Innovent; HKG:1801], a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong,…
SYDNEY, AUS – (ACN Newswire) – Leading Asia Pacific CRO Novotech commended the Turnbull Government’s Federal Budget decision to exclude clinical trials activity from…